Advertisement

Index by author

May 01, 1984; Volume 25,Issue 3

  1. Majewska, M D

    1. Modulation by calcium of gamma-aminobutyric acid (GABA) binding to GABAA and GABAB recognition sites in rat brain. Involvement of different mechanisms.
      M D Majewska and D M Chuang
      Molecular Pharmacology May 1984, 25 (3) 352-359;

  2. Maragoudakis, M E

    1. Human placenta aldose reductase. Forms sensitive and insensitive to inhibition by alrestatin.
      M E Maragoudakis, J Wasvary, H Hankin and P Gargiulo
      Molecular Pharmacology May 1984, 25 (3) 425-430;

  3. Mclaughlin, J T

    1. Mechanism of phencyclidine binding to the acetylcholine receptor from Torpedo electroplaque.
      R E Oswald, M J Bamberger and J T McLaughlin
      Molecular Pharmacology May 1984, 25 (3) 360-368;

  4. Mieyal, J J

    1. Substrate specificity of the monooxygenase activity of hemoglobin.
      D W Starke, K S Blisard and J J Mieyal
      Molecular Pharmacology May 1984, 25 (3) 467-475;

  5. Mitchell, M A

    1. Physical properties and lipid composition of brain membranes from ethanol tolerant-dependent mice.
      R A Harris, D M Baxter, M A Mitchell and R J Hitzemann
      Molecular Pharmacology May 1984, 25 (3) 401-409;

  6. Momparler, L F

    1. Kinetic interaction of 5-AZA-2'-deoxycytidine-5'-monophosphate and its 5'-triphosphate with deoxycytidylate deaminase.
      R L Momparler, M Rossi, J Bouchard, C Vaccaro, L F Momparler and S Bartolucci
      Molecular Pharmacology May 1984, 25 (3) 436-440;

  7. Momparler, R L

    1. Kinetic interaction of 5-AZA-2'-deoxycytidine-5'-monophosphate and its 5'-triphosphate with deoxycytidylate deaminase.
      R L Momparler, M Rossi, J Bouchard, C Vaccaro, L F Momparler and S Bartolucci
      Molecular Pharmacology May 1984, 25 (3) 436-440;

  8. Murphy, D L

    1. Interactions of phencyclidine with crayfish muscle membranes. Sensitivity to calcium channel antagonists and other drugs.
      E E El-Fakahany, A T Eldefrawi, D L Murphy, L G Aguayo, D J Triggle, E X Albuquerque and M E Eldefrawi
      Molecular Pharmacology May 1984, 25 (3) 369-378;
Back to top

In this issue

Advertisement